Dear %%FIRSTNAME%%,

GSK’s move to a new model of customer engagement has generated a great deal of debate. Indeed, many commentators remain skeptical that this ‘ethical’ model - especially the decoupling of sales incentives from prescription volume: is it robust enough to deliver results in the long-term?

This is what brought eyeforpharma to write an exclusive 24-page whitepaper entitled ‘GSK’s “new” ethical customer approach: Is it delivering?’ with the aim of analyzing the commercial success of the new customer approach.

Download this paper here and get exclusive insights from the following GSK leaders:

• George Katzourakis, Senior VP, Head of Europe
• Murray Stewart, Chief Medical Officer
• Denise Dewar, Head of Multichannel Marketing Excellence - EU, Canada & EMA

Providing you with insights on the impact, how it was done, what the future holds for customer engagement in pharma.

Download this exclusive paper here

Best regards,

Giselle Quartin
Head of Commercial, North America
eyeforpharma
Connect with me on linkedin.